I am delighted to have participated in the Second Annual Intellectual Property Redux Conference and to publish this essay. I rarely look back at my older articles, but in Fall 2018 I was asked to give a keynote address at a conference held by the Biotechnology Innovation Organization (BIO), where the organizers asked me to speak about 35 U.S.C. § 101 and patent-eligible subject matter. In preparing my remarks, I had the opportunity to refer back to one of my earliest scholarly pieces—a 2007 article entitled Ants, Elephant Guns, and Statutory Subject Matter, published in the Arizona State Law Journal.1 It turns out, over the past twelve years, the only thing that has substantially changed in that time is how I refer to the issue, now preferr...
Many of the problems with modern patent-eligibility analysis can be traced back to a fundamental phi...
In 2007, I published an essay in the Berkeley Technology Law Journal, titled A Burkean Perspective o...
This Article examines the intersection of patent law and academic science. It advances two novel cla...
Questions about whether software qualifies for patent protection are becoming increasingly more prev...
The US Supreme Court\u27s difficulty in promulgating a standard for patent-eligibility has not gone ...
The doctrine of patent-eligible subject matter is a mess, and it is weakening patent rights in this ...
In an era of tremendous and rapid technological advancement, coupled with the massive influence pate...
The U.S. Supreme Court has continued to require that patentable subject-matter eligibility determina...
In recent decades, the Patent and Trademark Office and the federal courts have dramatically expanded...
The U.S. Supreme Court has continued to require that patentable subject matter eligibility determina...
The doctrine of patent eligible subject matter under 35 U.S.C. § 101 is a “real mess.” Other apt ter...
This paper challenges the traditional “modernist” view that incentive-centered patent protection is ...
New Year’s Day prompts us to reflect on what the last 12 months have brought, so I’ve taken the oppo...
The high profile cases Bilski v. Kappos and Association for Molecular Pathology v. United States Pat...
On the face of it the doctrinal lines of disagreement around subject matter eligibility in US law an...
Many of the problems with modern patent-eligibility analysis can be traced back to a fundamental phi...
In 2007, I published an essay in the Berkeley Technology Law Journal, titled A Burkean Perspective o...
This Article examines the intersection of patent law and academic science. It advances two novel cla...
Questions about whether software qualifies for patent protection are becoming increasingly more prev...
The US Supreme Court\u27s difficulty in promulgating a standard for patent-eligibility has not gone ...
The doctrine of patent-eligible subject matter is a mess, and it is weakening patent rights in this ...
In an era of tremendous and rapid technological advancement, coupled with the massive influence pate...
The U.S. Supreme Court has continued to require that patentable subject-matter eligibility determina...
In recent decades, the Patent and Trademark Office and the federal courts have dramatically expanded...
The U.S. Supreme Court has continued to require that patentable subject matter eligibility determina...
The doctrine of patent eligible subject matter under 35 U.S.C. § 101 is a “real mess.” Other apt ter...
This paper challenges the traditional “modernist” view that incentive-centered patent protection is ...
New Year’s Day prompts us to reflect on what the last 12 months have brought, so I’ve taken the oppo...
The high profile cases Bilski v. Kappos and Association for Molecular Pathology v. United States Pat...
On the face of it the doctrinal lines of disagreement around subject matter eligibility in US law an...
Many of the problems with modern patent-eligibility analysis can be traced back to a fundamental phi...
In 2007, I published an essay in the Berkeley Technology Law Journal, titled A Burkean Perspective o...
This Article examines the intersection of patent law and academic science. It advances two novel cla...